Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. It has target discovery, research collaboration, and option agreement with Incyte Corporation to identify therapeutic targets with a focus on myeloproliferative neoplasms; and a license agreement with TMRC Co. Ltd. for the development and commercialization of tamibarotene. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Syros Pharmaceuticals Inc..
Syros Pharmaceuticals Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Syros Pharmaceuticals Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Syros Pharmaceuticals Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Syros Pharmaceuticals Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Syros Pharmaceuticals Inc. and all latest updates of the company are provided.
The 2025 version of Syros Pharmaceuticals Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Syros Pharmaceuticals Inc.- Key Facts
2.2 Syros Pharmaceuticals Inc.- Geographic Locations
2.3 Syros Pharmaceuticals Inc.- Subsidiaries and Affiliates
2.4 Syros Pharmaceuticals Inc.- Business Divisions
2.5 Syros Pharmaceuticals Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Syros Pharmaceuticals Inc. Strategic Analysis Review
3.1 Syros Pharmaceuticals Inc.- Key Strategies
3.2 Syros Pharmaceuticals Inc.- Company Outlook Statement
3.3 Syros Pharmaceuticals Inc.- SWOT Analysis
3.3.1 Syros Pharmaceuticals Inc.- Key Strengths
3.3.2 Syros Pharmaceuticals Inc.- Key Weaknesses
3.3.3 Syros Pharmaceuticals Inc.- Potential Opportunities
3.3.4 Syros Pharmaceuticals Inc.- Potential Threats
3.4 Syros Pharmaceuticals Inc.- Key Competitors
4. Business Description of the Company
4.1 Syros Pharmaceuticals Inc.- Business Overview
4.2 Syros Pharmaceuticals Inc.- Operations by Segment
5 Products and Services Details
5.1 Syros Pharmaceuticals Inc.- Key Products
5.2 Syros Pharmaceuticals Inc.- Key Service Areas
5.3 Syros Pharmaceuticals Inc.- Key Brands
6 Company Developments
6.1 Syros Pharmaceuticals Inc.- Company History
6.2 Syros Pharmaceuticals Inc.- Latest Developments
7 Financial Analysis
7.1 Syros Pharmaceuticals Inc.- Income Statements
7.2 Syros Pharmaceuticals Inc.- Balance Sheet
7.3 Syros Pharmaceuticals Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Syros Pharmaceuticals Inc.- Direct Competitors
8.2 Syros Pharmaceuticals Inc.- Competitor Financial Ratios comparison
8.3 Syros Pharmaceuticals Inc.- Competitor Stock Charts Comparison
8.4 Syros Pharmaceuticals Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!